A component of innate immunity prevents bacterial biofilm development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection. These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections. In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence. The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics. We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its iron-free form, apo-LF, inhibits the formation of biofilms by P. aeruginosa (Singh et al., 2002).”
From Iron in infection and immunity (2020) · cites this paper as Singh et al., 2002
In the citing paper
“The Fe-binding capacity of lactoferrin can also interfere with microbial virulence pathways such as biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
In the citing paper
“There are other examples, indicating a beneficial effect of targeting Fe, as illustrated for the ability of lactoferrin to prevent bacterial biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Self-citationThe Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“Methods Bacterial strains, plasmids, and growth conditions Pseudomonas aeruginosa strain PAO1 containing the GFP plasmid pMRP9-1 (ref”
BackgroundSelf-citationFlagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492 · cited 1×
“This led us to hypothesize that mucosal surfaces might possess an anti-biofilm defence, perhaps using antimicrobial factors, a phylogenetically conserved limb of the innate immune syste”
BackgroundQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519 · cited 1×
“In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistenc”
BackgroundSelf-citationWeinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198 · cited 1×
“These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infection”
BackgroundAlginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693 · cited 1×
“Pseudomonas aeruginosa biofilms for susceptibility tests were grown in a rotating disc reacto”
MethodSelf-citationThe Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 612
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Research works printed but not linked: 1
- Xiao, R. & Kisaalita, W. S. Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 143, 2509–2515 (1997) · DOI · Paper page
Cited by
Items 101–200 of 1,000
Iron acquisition and its control in Pseudomonas aeruginosa: Many roads lead to Rome
Poole, K. (2003) · Frontiers in Bioscience · doi:10.2741/1051 · Cited by 217
“aeruginosa biofilm formation does, however, highlight the probable significance of iron availability for biofilm formation (264).”
BackgroundWorld Journal of Pharmaceutical Sciences
(2021) · World Journal of Pharmaceutical Sciences · doi:10.54037/wjps · Cited by 245
Boyd, C. D., & O'Toole, G. A. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155705 · Cited by 237
“…cues such as osmolarity, pH, carbon availability, iron availability, oxygen tension, and temperature (Jackson et al. 2002a, 2002b; Lugtenberg et al. 1999; O'Toole & Kolter 1998b; O'Toole et al. 2000; Prigent-Combaret et al. 1999, 2001; Sauer et al. 2004; Singh et al. 2002; Thormann et al. 2006).”
BackgroundPhenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition
Wang, Y., Wilks, J. C., Danhorn, T., Ramos, I., Croal, L., & Newman, D. K. (2011) · Journal of Bacteriology · doi:10.1128/jb.00396-11 · Cited by 239
Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease
Verkman, A. S., Song, Y., & Thiagarajah, J. R. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00417.2002 · Cited by 230
“With regard to CF pathophysiology, it has been postulated that low ASL pH in CF favors bacterial survival and proliferation in the airway lumen by reducing electrostatic repulsion between the bacteria and airway surface, facilitating tighter biofilm formation and hindering access of immune cells (13, 72).”
BackgroundThe Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“The Fe-binding capacity of lactoferrin can also interfere with microbial virulence pathways such as biofilm formation [122].”
Characterization of Temporal Protein Production in Pseudomonas aeruginosa Biofilms
Southey-Pillig, C. J., Davies, D. G., & Sauer, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.23.8114-8126.2005 · Cited by 220
“aeruginosa and other biofilm-forming bacteria (5, 8, 59, 62, 74).”
BackgroundRole of lactoferrin in the tear film
FLANAGAN, J., & WILLCOX, M. (2009) · Biochimie · doi:10.1016/j.biochi.2008.07.007 · Cited by 221
“Apo-Lf, by chelating iron, stimulates twitching, a specialized form of surface motility, with the result that bacteria wander across biomaterial surfaces [91].”
BackgroundBiofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies
Afonso, A. C., Oliveira, D., Saavedra, M. J., Borges, A., & Simões, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158278 · Cited by 194
Recent advances in nanotechnology for eradicating bacterial biofilm
Sahli, C., Moya, S. E., Lomas, J. S., Gravier-Pelletier, C., Briandet, R., & Hémadi, M. (2022) · Theranostics · doi:10.7150/thno.67296 · Cited by 206
“This is because the smallest NPs release Fe3+ ions which interact with antimicrobial proteins, such as lactoferrin, believed to prevent colonization [159].”
BackgroundBiofilms in drinking water: problems and solutions
Chaves Simões, L., & Simões, M. (2013) · RSC Adv. · doi:10.1039/c2ra22243d · Cited by 215
Yarbrough, V. L., Winkle, S., & Herbst-Kralovetz, M. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu065 · Cited by 209
“Additional antimicrobial mechanisms exhibited by lactoferrin include, proteolytic degradation of virulence mechanisms from Type III secretion systems (Ochoa and Clearly, 2004), direct inhibition of host invasion (de Araujo and Giugliano, 2001), inhibition of biofilm formation (Singh et al., 2002), promotion of apoptos…”
BackgroundMolecular Interactions in Biofilms
Shirtliff, M. E., Mader, J. T., & Camper, A. K. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00198-9 · Cited by 214
Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production
Soong, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27920 · Cited by 215
Environmentally controlled bacterial vesicle-mediated export
Orench-Rivera, N., & Kuehn, M. J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12676 · Cited by 205
Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
Valenti, P., Rosa, L., Capobianco, D., Lepanto, M. S., Schiavi, E., Cutone, A., Paesano, R., & Mastromarino, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00376 · Cited by 218
“The low iron availability (10–18 M), hindering microbial growth, is a signal of health and wellness, while iron concentration higher than 10–18 M favors not only microbial replication but also the biofilm formation (56, 57) and persistence (44).”
BackgroundLactoferrin from Bovine Milk: A Protective Companion for Life
Superti, F. (2020) · Nutrients · doi:10.3390/nu12092562 · Cited by 204
Kuchma, S. L., Connolly, J. P., & O'Toole, G. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1441-1454.2005 · Cited by 204
“For example, recent studies have shown that the availability of both iron and oxygen can have profound impacts on biofilm formation by P. aeruginosa (5, 68 , 82).”
BackgroundAirway Gland Structure and Function
Widdicombe, J. H., & Wine, J. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00039.2014 · Cited by 204
Marshall, S. H., & Arenas, G. (2003) · Electronic Journal of Biotechnology · doi:10.2225/vol6-issue3-fulltext-1 · Cited by 212
Iron Salts Perturb Biofilm Formation and Disrupt Existing Biofilms of Pseudomonas aeruginosa
Musk, D. J., Banko, D. A., & Hergenrother, P. J. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.05.007 · Cited by 210
“aeruginosa PA14 was transformed with lac-controlled eGFP plasmid pMRP-9 in order to observe forchamber in a single unequivocal experiment [18].”
BackgroundMethodInfluentialTargeting Biofilms Therapy: Current Research Strategies and Development Hurdles
Jiang, Y., Geng, M., & Bai, L. (2020) · Microorganisms · doi:10.3390/microorganisms8081222 · Cited by 195
Cationic Polypeptides Are Required for Antibacterial Activity of Human Airway Fluid
Cole, A. M., Liao, H.-I., Stuchlik, O., Tilan, J., Pohl, J., & Ganz, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6985 · Cited by 205
“(36) revealed that, although physiologic concentrations of lacto-”
BackgroundControlling Bacterial Biofilms
Richards, J. J., & Melander, C. (2009) · ChemBioChem · doi:10.1002/cbic.200900317 · Cited by 189
Keeping Their Options Open: Acute versus Persistent Infections
Furukawa, S., Kuchma, S. L., & O'Toole, G. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.4.1211-1217.2006 · Cited by 204
“It is likely that multiple signals are involved in this decision-making process and that they are related to the metabolism of the organism, for example, the availability of iron and other nutrients or aerobic versus anaerobic conditions ( 50 , 65).”
BackgroundMoreau-Marquis, S., O'Toole, G. A., & Stanton, B. A. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0299oc · Cited by 204
Vishwakarma, A., Dang, F., Ferrell, A., Barton, H. A., & Joy, A. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02324 · Cited by 201
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 196
“Several groups have targeted the processes necessary for biofilms to evolve into mature structures, such as quorum-sensing and iron acquisition (96, 97).”
BackgroundMucin– Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance
Landry, R. M., An, D., Hupp, J. T., Singh, P. K., & Parsek, M. R. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04941.x · Cited by 201
“aeruginosa biofilm development and structure (O’Toole and Kolter, 1998; Stoodley et al., 2001; Singh et al., 2002; Klausen et al., 2003a).”
BackgroundSelf-citationPatriquin, G. M., Banin, E., Gilmour, C., Tuchman, R., Greenberg, E. P., & Poole, K. (2008) · Journal of Bacteriology · doi:10.1128/jb.01473-07 · Cited by 191
Self-citationPrithiviraj, B., Bais, H. P., Weir, T., Suresh, B., Najarro, E. H., Dayakar, B. V., Schweizer, H. P., & Vivanco, J. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5319-5328.2005 · Cited by 195
“aeruginosa and could protect against persistent infections (61).”
BackgroundYang, L., Liu, Y., Wu, H., Song, Z., Høiby, N., Molin, S., & Givskov, M. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00858.x · Cited by 184
“In 2002, Singh et al. reported that iron chelator lactoferrin stimulates twitching motility and prevents biofilm formation by P. aeruginosa (Singh et al., 2002).”
BackgroundPseudomonas aeruginosa biofilms and their partners in crime
Cendra, M. D. M., & Torrents, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107734 · Cited by 176
Hill, K. E., Malic, S., McKee, R., Rennison, T., Harding, K. G., Williams, D. W., & Thomas, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq105 · Cited by 188
Moreau-Marquis, S., Bomberger, J. M., Anderson, G. G., Swiatecka-Urban, A., Ye, S., O'Toole, G. A., & Stanton, B. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00391.2007 · Cited by 186
Biofilm Formation by Hyperpiliated Mutants of Pseudomonas aeruginosa
Chiang, P., & Burrows, L. L. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2374-2378.2003 · Cited by 179
“(16) recently reported that sequestration of iron by lactoferrin increased the twitching motility of P.”
BackgroundChristensen, L. D., van Gennip, M., Jakobsen, T. H., Alhede, M., Hougen, H. P., Hoiby, N., Bjarnsholt, T., & Givskov, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks002 · Cited by 177
Biologically Active and Antimicrobial Peptides from Plants
Salas, C. E., Badillo-Corona, J. A., Ramírez-Sotelo, G., & Oliver-Salvador, C. (2015) · BioMed Research International · doi:10.1155/2015/102129 · Cited by 174
“These attributes provide natural alternatives with potential to be used as food ingredients in a variety of applications [58, 127].”
BackgroundTiming and Localization of Rhamnolipid Synthesis Gene Expression in Pseudomonas aeruginosa Biofilms
Lequette, Y., & Greenberg, E. P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.1.37-44.2005 · Cited by 176
“Often after cell division the two daughter cells stop twitching and begin to form a microcolony (34).”
BackgroundSelf-citationImmune Responses to Pseudomonas aeruginosa Biofilm Infections
Moser, C., Jensen, P. Ø., Thomsen, K., Kolpen, M., Rybtke, M., Lauland, A. S., Trøstrup, H., & Tolker-Nielsen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625597 · Cited by 170
Environmental Influences on Biofilm Development
Goller, C. C., & Romeo, T. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_3 · Cited by 164
Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes
Lyte, M., Freestone, P. P., Neal, C. P., Olson, B. A., Haigh, R. D., Bayston, R., & Williams, P. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12231-3 · Cited by 177
Danese, P. N. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00192-8 · Cited by 175
Biofilms, Antimicrobial Resistance, and Airway Infection
Prince, A. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr021776 · Cited by 177
Yang, L., Nilsson, M., Gjermansen, M., Givskov, M., & Tolker‐Nielsen, T. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06934.x · Cited by 172
“…© 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 1380–1392 supplying them with iron, the Fe-pyoverdine produced by the stalk cells may be required for settling the migrating bacteria on the cap, as iron limitation has been shown to induce twitching motility (Singh et al., 2002).”
BackgroundMannan‐binding lectin and its role in innate immunity
Kilpatrick, D. C. (2002) · Transfusion Medicine · doi:10.1046/j.1365-3148.2002.00408.x · Cited by 175
Biofilms in wounds: management strategies
Rhoads, D. D., Wolcott, R. D., & Percival, S. L. (2008) · Journal of Wound Care · doi:10.12968/jowc.2008.17.11.31479 · Cited by 174
Burns, biofilm and a new appraisal of burn wound sepsis
Kennedy, P., Brammah, S., & Wills, E. (2010) · Burns · doi:10.1016/j.burns.2009.02.017 · Cited by 173
“[32] Singh PK, Parsek MR, Greenberg EP, Welsh MJ.”
BackgroundFerrous Iron Is a Significant Component of Bioavailable Iron in Cystic Fibrosis Airways
Hunter, R. C., Asfour, F., Dingemans, J., Osuna, B. L., Samad, T., Malfroot, A., Cornelis, P., & Newman, D. K. (2013) · mBio · doi:10.1128/mbio.00557-13 · Cited by 173
“Consistent with previous studies (10, 14), 100 M conalbumin prevented biofilm formation by 66% (P 0.”
ResultOpportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis
GOMEZ, M., & PRINCE, A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.12.005 · Cited by 172
Rogan, M. P., Taggart, C. C., Greene, C. M., Murphy, P. G., O’Neill, S. J., & McElvaney, N. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/423821 · Cited by 171
“aeruginosa biofilm [10].”
BackgroundInfluentialNutritional roles of lactoferrin
Lönnerdal, B. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328328d13e · Cited by 170
How Biofilms Evade Host Defenses
Roilides, E., Simitsopoulou, M., Katragkou, A., & Walsh, T. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0012-2014 · Cited by 157
“It is possible that exotoxins or other components produced by P. aeruginosa and immune cells, respectively, may play a role (46, 67).”
BackgroundInfluentialHendricks, M. R., Lashua, L. P., Fischer, D. K., Flitter, B. A., Eichinger, K. M., Durbin, J. E., Sarkar, S. N., Coyne, C. B., Empey, K. M., & Bomberger, J. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516979113 · Cited by 168
“aeruginosa and other bacterial species (18, 23, 24, 38).”
BackgroundGlick, R., Gilmour, C., Tremblay, J., Satanower, S., Avidan, O., Déziel, E., Greenberg, E. P., Poole, K., & Banin, E. (2010) · Journal of Bacteriology · doi:10.1128/jb.01601-09 · Cited by 165
“aeruginosa observed under low-iron conditions (40).”
BackgroundInfluentialSelf-citationBioinorganic antimicrobial strategies in the resistance era
Regiel-Futyra, A., Dąbrowski, J. M., Mazuryk, O., Śpiewak, K., Kyzioł, A., Pucelik, B., Brindell, M., & Stochel, G. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.005 · Cited by 164
Martinez, L. R., & Casadevall, A. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6350-6362.2005 · Cited by 165
“have recently demonstrated that lactoferrin could prevent development of bacterial biofilms (36).”
BackgroundAntimicrobial Defense Systems in Saliva
van ‘t Hof, W., Veerman, E. C. I., Nieuw Amerongen, A. V., & Ligtenberg, A. J. M. (2014) · Monographs in Oral Science · doi:10.1159/000358783 · Cited by 156
Antifouling potential of cyanobacteria: a mini-review
Dahms, H.-U., Ying, X., & Pfeiffer, C. (2006) · Biofouling · doi:10.1080/08927010600967261 · Cited by 161
Insight into the microbial multicellular lifestyle via flow‐cell technology and confocal microscopy
Pamp, S. J., Sternberg, C., & Tolker‐Nielsen, T. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20685 · Cited by 155
“surface via type IV pili or flagella activity (29,30,79,80).”
BackgroundSusceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
Dean, S. N., Bishop, B. M., & van Hoek, M. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00128 · Cited by 159
Malik, E., Dennison, S. R., Harris, F., & Phoenix, D. A. (2016) · Pharmaceuticals · doi:10.3390/ph9040067 · Cited by 179
“aeruginosa [157] and the protein was found able to synergise the activity of other 315 antimicrobials against biofilms formed from P.”
BackgroundVentilator Associated Pneumonia: Evolving Definitions and Preventive Strategies
Mietto, C., Pinciroli, R., Patel, N. G., & Berra, L. M. (2013) · Respiratory Care · doi:10.4187/respcare.02380 · Cited by 211
Modification of iron regulation by the inflammatory response
WEISS, G. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.001 · Cited by 161
Iron overload following red blood cell transfusion and its impact on disease severity
Ozment, C. P., & Turi, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.010 · Cited by 159
Segal, L. N., Clemente, J. C., Li, Y., Ruan, C., Cao, J., Danckers, M., Morris, A., Tapyrik, S., Wu, B. G., Diaz, P., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.003 · Cited by 160
“Failure of the immune response to inhibit biofilm formation could predispose to dysbiosis with anaerobes (Singh et al., 2002; Wakabayashi et al., 2009).”
BackgroundJorge, P., Lourenço, A. M. G., & Pereira, M. O. (2012) · Biofouling · doi:10.1080/08927014.2012.728210 · Cited by 174
“For example, lactoferrin inhibits biofilm formation in P. aeruginosa due to its iron-chelating properties, increasing surface motility and causing the bacterial cells to wander around the surface, forming thin, flat biofilms (Singh et al. 2002).”
BackgroundBiofilms and host response – helpful or harmful
Moser, C., Pedersen, H. T., Lerche, C. J., Kolpen, M., Line, L., Thomsen, K., Høiby, N., & Jensen, P. Ø. (2017) · APMIS · doi:10.1111/apm.12674 · Cited by 155
“concentrations of lactoferrin (60), which may prevent biofilm formation (61).”
BackgroundWu, Y., & Outten, F. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01086-08 · Cited by 185
“aeruginosa biofilm formation, and it has been suggested that this may play a role in limiting infection (46).”
BackgroundPolymer Multilayers with pH-Triggered Release of Antibacterial Agents
Pavlukhina, S., Lu, Y., Patimetha, A., Libera, M., & Sukhishvili, S. (2010) · Biomacromolecules · doi:10.1021/bm100975w · Cited by 153
Biofilms and their relevance to veterinary medicine
Clutterbuck, A. L., Woods, E. J., Knottenbelt, D. C., Clegg, P., Cochrane, C. A., & Percival, S. L. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2006.12.029 · Cited by 190
The Immunological Components of Human Milk
Blewett, H., Cicalo, M. C., Holland, C. D., & Field, C. J. (2008) · Advances in food and nutrition research · doi:10.1016/s1043-4526(07)00002-2 · Cited by 182
“These biofilms are encased surface communities that are resistant to host defense mechanisms and antibiotics (Singh et al., 2002).”
BackgroundOjha, A., & Hatfull, G. F. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05935.x · Cited by 148
“, 2005), while chelation with lactoferrin is strongly inhibitory (Singh et al., 2002).”
BackgroundGenetic control of bacterial biofilms
Wolska, K. I., Grudniak, A. M., Rudnicka, Z., & Markowska, K. (2016) · Journal of Applied Genetics · doi:10.1007/s13353-015-0309-2 · Cited by 154
“…participation in iron metabolism; it was shown that too low or too high concentration of iron results in the inhibition of biofilm formation (Singh et al. 2002). c-di-GMP signaling In general, high c-di-GMP level induces the biosynthesis of adhesins and matrix polysaccharides and inhibits…”
BackgroundProteomic Analysis of the Systemic Immune Response of Drosophila
Levy, F., Bulet, P., & Ehret‐Sabatier, L. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300114-mcp200 · Cited by 169
“Furthermore, lactoferrin, a related bactericidal and bacteriostatic molecule, was also implicated in the prevention of Pseudomonas aeruginosa biofilm development at concentrations below those that kill or prevent growth of the bacteria ( 56 ).”
BackgroundMcGinnigle, S., Naroo, S. A., & Eperjesi, F. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2011.11.003 · Cited by 153
“It can also bind with the lipopolysaccharide from Gram negative bacteria, increasing the membrane permeability— thus causing osmotic shock and, in the right concentration, inhibiting bacterial biofilm formation on contact lenses.(238,288,289) There is also evidence to suggest it has a role in UV protection.”
Lactoferrin: Role in iron homeostasis and host defense against microbial infection
Ward, P. P., & Conneely, O. M. (2004) · BioMetals · doi:10.1023/b:biom.0000027693.60932.26 · Cited by 169
“et al demonstrated that LF could prevent the formation of Pseudomonas aeruginosa biofilms in vitro (Singh et al. 2002).”
BackgroundInfluentialEngler, A. C., Shukla, A., Puranam, S., Buss, H. G., Jreige, N., & Hammond, P. T. (2011) · Biomacromolecules · doi:10.1021/bm2000583 · Cited by 151
Phenazines affect biofilm formation by Pseudomonas aeruginosa in similar ways at various scales
Ramos, I., Dietrich, L. E. P., Price‐Whelan, A., & Newman, D. K. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.01.003 · Cited by 152
“While the flow cell system allows the fate of individual cells to be monitored over time (Singh et al., 2002), a major disadvantage to this technique is the impracticality of running many biofilms at once.”
BackgroundDoes Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
Kirisits, M. J., & Parsek, M. R. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00817.x · Cited by 144
“The formation of a flat biofilm is characterized by significant surface motility (Singh et al., 2002; Klausen et al., 2003a).”
BackgroundSelf-citationKlausen, M., Gjermansen, M., Kreft, J.-U., & Tolker-Nielsen, T. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00280.x · Cited by 140
Phenotypic Characterization of Streptococcus pneumoniae Biofilm Development
Allegrucci, M., Hu, F. Z., Shen, K., Hayes, J., Ehrlich, G. D., Post, J. C., & Sauer, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2325-2335.2006 · Cited by 141
“aeruginosa and other biofilm-forming bacteria (1, 11, 37, 62, 69, 72).”
Pseudomonas biofilms: possibilities of their control
Masák, J., Čejková, A., Schreiberová, O., & Řezanka, T. (2014) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12344 · Cited by 167
“In correlation with the findings of Singh et al. (2002) mentioned above, they indicated that the optimal concentration of iron for the formation of P. aeruginosa biofilm is in the range of about 1–100 lM. Microorganisms can produce simple molecules that inhibit the formation or decompose existing…”
BackgroundResultLopez-Medina, E., Fan, D., Coughlin, L. A., Ho, E. X., Lamont, I. L., Reimmann, C., Hooper, L. V., & Koh, A. Y. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005129 · Cited by 143
Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic
Ammons, M. C., & Copié, V. (2013) · Biofouling · doi:10.1080/08927014.2013.773317 · Cited by 141
“aeruginosa demonstrated that lactoferrin inhibits biofilm formation and disrupts existing biofilms either by preventing lectin-dependent bacterial adhesion or stimulating bacterial motility (Singh et al. 2002; LesmanMovshovich et al. 2003).”
InfluentialWakabayashi, H., Yamauchi, K., Kobayashi, T., Yaeshima, T., Iwatsuki, K., & Yoshie, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01688-08 · Cited by 136
“aeruginosa by an iron-chelating mechanism (36).”
Antimicrobial proteins and polypeptides in pulmonary innate defence
Rogan, M. P., Geraghty, P. M., Greene, C. M., O'Neill, S. J., Taggart, C. C., & McElvaney, N. G. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-29 · Cited by 156
“Lactoferrin has recently been shown to inhibit Pseudomonas biofilm formation [12].”
BackgroundChristensen, L. D., Moser, C., Jensen, P. Ø., Rasmussen, T. B., Christophersen, L., Kjelleberg, S., Kumar, N., Høiby, N., Givskov, M., & Bjarnsholt, T. (2007) · Microbiology · doi:10.1099/mic.0.2007/006122-0 · Cited by 139
“One explanation gaining momentum is that the biofilm mode of growth protects the colonizing bacteria and enables them to withstand host immune responses and exhibit high tolerance to treatment with the highest deliverable doses of antibiotics (Bjarnsholt et al., 2005a; Costerton et al., 1999; Hentzer et al., 2003; Høi…”
InfluentialMechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials
Ranieri, M. R. M., Whitchurch, C. B., & Burrows, L. L. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.07.006 · Cited by 146
Oxidative stress responses in biofilms
Nizer, W. S. D. C., Adams, M. E., Allison, K. N., Montgomery, M. C., Mosher, H., Cassol, E., & Overhage, J. (2024) · Biofilm · doi:10.1016/j.bioflm.2024.100203 · Cited by 149
Raffa, R. B., Iannuzzo, J. R., Levine, D. R., Saeid, K. K., Schwartz, R. C., Sucic, N. T., Terleckyj, O. D., & Young, J. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075150 · Cited by 139
“Natural defenses against bacteria, such as mucosal secretions, are less effective once biofilms have formed (Singh et al., 2002).”
BackgroundInterdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa
Kang, D., & Kirienko, N. V. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-8114-3 · Cited by 135
“Iron acquisition is necessary for biofilm formation in P. aeruginosa In a seminal study, Singh and colleagues reasoned that if biofilms were such a common occurrence in human infections, the innate immune system should mount some defense against them (Singh et al., 2002).”
Regulation of Biofilm Exopolysaccharide Biosynthesis and Degradation in Pseudomonas aeruginosa
Luyan, Z., Wang, D., Liu, Y., Zhang, Z., & Wozniak, D. J. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041320-111355 · Cited by 151
The diabetic foot: The importance of biofilms and wound bed preparation
Davis, S. C., Martinez, L. C., & Kirsner, R. S. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0076-x · Cited by 149
Borcherding, J. A., Baltrušaitis, J., Chen, H., Stebounova, L. V., Wu, C., Rubasinghege, G., Mudunkotuwa, I. A., Caraballo, J. C., Zabner, J., Grassian, V. H., et al. (2014) · Environmental Science Nano · doi:10.1039/c3en00029j · Cited by 134
Wu, Y., Shu, R., Luo, L., Lh, G., & Xie, Y. (2009) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01172.x · Cited by 145
Jin, Y., Zhang, T., Samaranayake, Y. H., Fang, H. H. P., Yip, H. K., & Samaranayake, L. P. (2005) · Mycopathologia · doi:10.1007/s11046-004-6987-7 · Cited by 150
“albicans biofilms were grown in a RDR comprising a working chamber (250 ml) and a waste tank [15, 16].”
MethodTolker‐Nielsen, T. (2014) · APMIS · doi:10.1111/apm.12335 · Cited by 125
“aeruginosa biofilms under conditions of iron limitation [162, 163, 174].”
BackgroundThe impact of transition metals on bacterial plant disease
Fones, H. N., & Preston, G. M. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12004 · Cited by 148
Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., & Ghannoum, M. A. (2007) · Infection and Immunity · doi:10.1128/iai.01841-06 · Cited by 130
“One example of such an inhibitory molecule is lactoferrin, a common secretory component of human neutrophils, which has been shown to inhibit P. aeruginosa biofilm production ( 37 ).”
Background
Metadata
- Authors
- Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J.
- Affiliations
- University of Iowa (US)
- Northwestern University (US)
- Corresponding author
- Singh, Pradeep K.
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6888
- Pages
- 552-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1970294462
- Cited by
- 1,026
- References
- 31
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 24 · 2023: 35 · 2022: 34 · 2021: 45 · 2020: 37 · 2019: 33 · 2018: 43 · 2017: 43 · 2016: 43 · 2015: 52 · 2014: 55 · 2013: 37 · 2012: 69
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (K24HL102246)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- lactoferrin, bacterial biofilm formation, Pseudomonas aeruginosa, innate immunity, iron chelation, twitching motility, surface motility, mucosal protection, chronic bacterial infection
- MeSH terms
- Chronic Disease, Conalbumin, Dose-Response Relationship, Drug, Humans, Hydrogen Peroxide, Immunity, Innate, Iron, Iron Chelating Agents, Lactoferrin, Pseudomonas aeruginosa, Tobramycin, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.